EPISCOPE
LIVE

Serial Number

99370521

Owner

SPOC Proteomics Inc

Filing Date

Sep 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EPISCOPE Trademark

Serial Number: 99370521

EPISCOPE is a trademark filed by SPOC Proteomics Inc on September 2, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

SPOC Proteomics Inc (11 trademarks)

7201 E Henkel Way, Suite 285
Scottsdale, AZ 85255

Entity Type: 03

Trademark Details

Filing Date

September 2, 2025

Registration Date

Not Registered

Goods & Services

Medical laboratory research instruments for evaluating pharmaceuticals, such as antibodies; Plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Sensor chips for scientific use

Drug discovery services; Pharmaceutical products development; Pharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical drug development services; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Technical research in the field of pharmaceutical studies; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of pharmaceutical preparations; Pharmaceutical research in the field of therapeutic discovery and development; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Research on the subject of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Development of pharmaceuticals for cell and gene therapies; Testing of pharmaceuticals for cell and gene therapies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Laboratory services for the production of pharmaceuticals in the nature of testing of pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies; Medical research; Medical research services; Medical research laboratory services; Medical research in the field of oncology; Medical research in the field of infectious diseases; Medical research in the field of pathology; Medical research in the field of rare diseases; Medical research services in the field of cancer; Medical research laboratory services in the field of oncology; Research and development services in the field of medical preparations; Scientific research for medical purposes in the area of cancerous diseases; Providing information about medical research in the field of therapeutic discovery and development; Medical and scientific research in the field of cancer treatment and diagnosis; Technology research in the field of therapeutic discovery and development; Medical research in the field of therapeutic discovery and development; Research and development in the field of therapeutic discovery and development; Scientific research for medical purposes in the field of therapeutic discovery and development; Medical and scientific research in the field of therapeutic discovery and development; Medical and scientific research information in the field of therapeutic discovery and development; Laboratory services for biomanufacturing; Laboratory services for biomanufacturing of antibodies, peptides, and proteins for therapeutic evaluation; Biological research; Biological research and analysis; Biological research laboratory services; Biological research in the field of therapeutic discovery and development; Research in the field of synthetic biology; Biomedical research services; Biomedical research in the field of therapeutic discovery and development; Biotechnology research; Research and development in the field of biotechnology; Research and development services in the field of biotechnology; Biotechnology research in the field of therapeutic discovery and development

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 2, 2025 MAFR
NEW APPLICATION ENTERED
Sep 2, 2025 NWAP